An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung Cancer
NCT ID: NCT01488331
Last Updated: 2016-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
217 participants
OBSERVATIONAL
2010-06-30
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of locally advanced or metastatic non-small cell lung cancer (NSCLC, stage III/IV)
* Treatment with Tarceva monotherapy and not progressing after at least 9 months at the date of study start
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abbeville, , France
Agen, , France
Aix-en-Provence, , France
Aix-en-Provence, , France
Ajaccio, , France
Amiens, , France
Angers, , France
Annecy, , France
Aubagne, , France
Auxerre, , France
Bastia, , France
Bordeaux, , France
Bourg-en-Bresse, , France
Brest, , France
Brest, , France
Bron, , France
Bry-sur-Marne, , France
Caen, , France
Cagnes-sur-Mer, , France
Chalon-sur-Saône, , France
Chambray-lès-Tours, , France
Chaumont, , France
Chauny, , France
Cholet, , France
Clamart, , France
Clermont-Ferrand, , France
Colmar, , France
Compiègne, , France
Coquelles, , France
Cornebarrieu, , France
Creil, , France
Créteil, , France
Dax, , France
Dijon, , France
Draguignan, , France
Eaubonne, , France
Fréjus, , France
Gap, , France
Gleizé, , France
Helfaut, , France
Hyères, , France
La Chaussée-Saint-Victor, , France
La Roche-sur-Yon, , France
La Rochelle, , France
La Source, , France
La Tronche, , France
Le Plessis-Robinson, , France
Libourne, , France
Limoges, , France
Longjumeau, , France
Lyon, , France
Lyon, , France
Meaux, , France
Metz, , France
Meudon, , France
Montauban, , France
Montpellier, , France
Mulhouse, , France
Nancy, , France
Nantes, , France
Nevers, , France
Paris, , France
Paris, , France
Paris, , France
Perpignan, , France
Perpignan, , France
Pierre-Bénite, , France
Pontoise, , France
Reims, , France
Reims, , France
Rennes, , France
Rouen, , France
Saint-Aubin-lès-Elbeuf, , France
Saint-Avold, , France
Saint-Brieuc, , France
Saint-Jean, , France
Saint-Priest-en-Jarez, , France
Saint-Priest-en-Jarez, , France
Saint-Quentin, , France
Salon-de-Provence, , France
Senlis, , France
Strasbourg, , France
Strasbourg, , France
Strasbourg, , France
Tarbes, , France
Thionville, , France
Toulon, , France
Toulon, , France
Toulouse, , France
Tours, , France
Vénissieux, , France
Vichy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML22973
Identifier Type: -
Identifier Source: org_study_id